
FDA Approves Zepbound: First Sleep Apnea Drug Reduces Breathing Events by 25/hour, 18% Weight Loss
The U.S. Food and Drug Administration (FDA) has approved Zepbound (tirzepatide), marking the first medication authorized for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The approval comes